Provided herein are compositions, methods, and systems related to 3D printing a reactive vaterite cement composition, comprising feeding a composition comprising reactive vaterite cement through a 3D printing machine; printing a 3D printed reactive vaterite cement product; and curing the 3D printed reactive vaterite cement product by transforming reactive vaterite cement in the 3D printed reactive vaterite cement product to aragonite and/or calcite during and/or after the curing.

The present invention relates to a process for producing calcium silicate hydrate under hydrothermal conditions, wherein an organic compound is added in at least one of the process steps and wherein the organic compound has a molecular weight of 100 to 600 g/mol and from 0.02 to 0.035 functional groups per gram of the organic compound, wherein the functional groups being selected from —OH, —COOH, 'COOM.sub.a, —SO.sub.3H or —SO.sub.3M.sub.a, or —C(═O)H, wherein M is hydrogen, a mono-, di- or trivalent metal cation, ammonium ion or an organic amine radical and a is ⅓, ½ or 1. Further the invention is directed to the calcium silicate hydrate produceable according to the process of the present invention and its use as curing accelerator for hydraulic binders.

The present invention relates to a process for producing calcium silicate hydrate under hydrothermal conditions, wherein an organic compound is added in at least one of the process steps and wherein the organic compound has a molecular weight of 100 to 600 g/mol and from 0.02 to 0.035 functional groups per gram of the organic compound, wherein the functional groups being selected from —OH, —COOH, 'COOM.sub.a, —SO.sub.3H or —SO.sub.3M.sub.a, or —C(═O)H, wherein M is hydrogen, a mono-, di- or trivalent metal cation, ammonium ion or an organic amine radical and a is ⅓, ½ or 1. Further the invention is directed to the calcium silicate hydrate produceable according to the process of the present invention and its use as curing accelerator for hydraulic binders.

The use of calcium aluminate cement in autoclaved cement products, cementitious compositions suitable for forming the autoclaved cement products, and methods for making the cementitious compositions and autoclaved cement products.

The use of calcium aluminate cement in autoclaved cement products, cementitious compositions suitable for forming the autoclaved cement products, and methods for making the cementitious compositions and autoclaved cement products.

A synthetic source rock including roasted tea powder and inorganic material. A technique for preparing the synthetic source rock, including grinding tea leaves to give tea powder, roasting the tea powder at a roasting temperature to give a roasted tea powder, and determining composition and porosity of the roasted tea powder.

A synthetic source rock including roasted tea powder and inorganic material. A technique for preparing the synthetic source rock, including grinding tea leaves to give tea powder, roasting the tea powder at a roasting temperature to give a roasted tea powder, and determining composition and porosity of the roasted tea powder.

In a process for manufacturing a component for an emissions treatment unit, green ceramic product is extruded through a die to form an extrusion having a honeycomb substrate structure with an array of parallel, linear tubular cells extending along its length, the cells bounded by walls dividing adjacent cells from one another. A ceramic unit is obtained by cutting off, curing and firing a length of the extrusion a length of the extrusion. Following the firing, a mixture of a flowable, uncured curable material and a particulate metal component is injected from an end of the ceramic unit into selected ones of the cells so as to block the selected cells over at least a part of their lengths while maintaining all of the walls of the ceramic unit. The injected mixture is then cured to render it solid.

In a process for manufacturing a component for an emissions treatment unit, green ceramic product is extruded through a die to form an extrusion having a honeycomb substrate structure with an array of parallel, linear tubular cells extending along its length, the cells bounded by walls dividing adjacent cells from one another. A ceramic unit is obtained by cutting off, curing and firing a length of the extrusion a length of the extrusion. Following the firing, a mixture of a flowable, uncured curable material and a particulate metal component is injected from an end of the ceramic unit into selected ones of the cells so as to block the selected cells over at least a part of their lengths while maintaining all of the walls of the ceramic unit. The injected mixture is then cured to render it solid.

A method of preparing an inorganic binder for medical use according to an embodiment of the present disclosure includes preparing a starting material using a-TCP powder and phosphate powder each of which has a predetermined particle size, producing a paste having a predetermined viscosity that is suitable for formation of a molded article having a predetermined shape by homogeneously mixing the starting material, adding water or saline to the homogeneously mixed starting material, and kneading the resulting mixture, subjecting the molded article to hydration reaction, and washing and drying the molded article having undergone the hydration reaction to obtain an inorganic binder containing OCP and HA crystal phases.